Please provide your email address to receive an email when new articles are posted on . 63.6% of patients consulted for drug allergy were recommended for more testing. 32.5% of these patients did not ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Most drug allergy labels persist due to limited access ...
MILWAUKEE, Feb. 13, 2026 /PRNewswire/ -- Drug allergy labels (DAL) are common and largely unevaluated in children with primary immunodeficiencies, which could lead to worse patient outcomes, according ...
More than 20% of the population is suspected to have a penicillin allergy, yet less than 5% have this allergy. Because a recorded "penicillin allergy" entails altered antibiotic management, risk for ...
Food allergy sufferers have a new weapon in their fight against severe symptoms. The U.S. Food and Drug Administration (FDA) has given the injectable Xolair (omalizumab) the green light for use in ...
Q: Some of our organizations have reflected on surveyor’s expectations regarding “crossovers” of drug allergies and what the facility does to assist in screening for those. How would you suggest we ...
Omalizumab, currently used to treat asthma, has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. R. Sharon Chinthrajah examines 12-year-old Anabelle Terry, who is allergic to nuts, at the Stanford Allergy Clinic in Palo ...
Laura Pleasants doesn’t leave her house without at least six EpiPens — autoinjectors about the size and shape of a whiteboard marker that contain medication that can calm a body’s allergic reaction.
Kevin Wang and Annie Marqueling’s son Liam was 8 months old when he broke out in hives all over his body after eating a few bits of a scrambled egg. An allergy test revealed Liam was allergic to eggs, ...
Jasper Therapeutics’ monoclonal antibody briquilimab is effective at preventing mast-cell induced anaphylaxis and asthma in mice, new data suggest. In an oral presentation and two posters at the ...
WASHINGTON - A new food allergy drug has been approved by the U.S. Food and Drug Administration, potentially lessening the severity of reactions to foods like peanuts, milk, eggs, wheat, and cashews.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results